Ibuprofen Kabi

Ibuprofen, the active ingredient in Ibuprofen Kabi, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an intravenous solution for intravenous use. It is employed in hospital settings to relieve acute pain, postoperative pain, fever, and inflammatory conditions such as musculoskeletal inflammation, and related swelling among adult patients, and may be selected when oral therapy is unsuitable, providing rapid onset of analgesia.

GNH USA supplies Ibuprofen Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and health‑care institutions worldwide.

Ibuprofen Kabi is used to manage pain and inflammation through cyclo‑oxygenase inhibition.

Acute pain: provides rapid analgesia for sudden severe pain episodes. Post‑operative pain: reduces pain after surgical procedures, facilitating recovery. Fever: lowers elevated body temperature in febrile patients. Inflammatory conditions: diminishes swelling and discomfort in acute inflammatory states such as musculoskeletal injury.

Intravenous ibuprofen may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Injection site pain

Serious or Rare Side Effects: - Severe gastrointestinal bleeding - Anaphylactic reaction - Acute renal failure

When using Ibuprofen Kabi, clinicians should observe several safety measures.

Assess renal function: evaluate baseline kidney function before use. Monitor bleeding risk: avoid in patients with active ulcer or coagulopathy. Use lowest effective dose: limit duration to reduce adverse events. Avoid in known hypersensitivity: contraindicated in patients allergic to ibuprofen or other NSAIDs. Use cautiously in cardiovascular disease: consider risk of thrombotic events. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofen Kabi can interact with other medicines; careful review is required.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - ACE inhibitors: reduced antihypertensive effect and potential renal impairment. - Other NSAIDs: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance renal effects. - SSRIs: increased bleeding tendency.